These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 22271505)

  • 1. Reply to the letter to the editor of francisco José Fernández-Fernández et al.
    Seitz M
    Swiss Med Wkly; 2012; 142():w13504. PubMed ID: 22271505
    [No Abstract]   [Full Text] [Related]  

  • 2. Might tocilizumab be useful in patients with giant-cell arteritis and normal ESR?
    Fernández-Fernández FJ; Ameneiros-Lago E; Sesma P
    Swiss Med Wkly; 2012; 142():w13503. PubMed ID: 22271487
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series.
    Seitz M; Reichenbach S; Bonel HM; Adler S; Wermelinger F; Villiger PM
    Swiss Med Wkly; 2011; 141():w13156. PubMed ID: 21243547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secukinumab for the maintenance of glucocorticoid-free remission in a patient with giant cell arteritis and psoriatic arthritis.
    Rotar Ž; Tomšic M; Hocevar A
    Rheumatology (Oxford); 2018 May; 57(5):934-936. PubMed ID: 29394408
    [No Abstract]   [Full Text] [Related]  

  • 5. Interleukin 6 blockade as steroid-sparing treatment for 2 patients with giant cell arteritis.
    Sciascia S; Rossi D; Roccatello D
    J Rheumatol; 2011 Sep; 38(9):2080-1. PubMed ID: 21885526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Anti-IL-6 : new therapeutic trends].
    Candil M; Zufferey P
    Rev Med Suisse; 2017 Jan; 13(544-545):105-109. PubMed ID: 28703549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritis.
    Beyer C; Axmann R; Sahinbegovic E; Distler JH; Manger B; Schett G; Zwerina J
    Ann Rheum Dis; 2011 Oct; 70(10):1874-5. PubMed ID: 21515917
    [No Abstract]   [Full Text] [Related]  

  • 8. Infliximab as monotherapy in giant cell arteritis.
    Uthman I; Kanj N; Atweh S
    Clin Rheumatol; 2006 Feb; 25(1):109-10. PubMed ID: 15902519
    [No Abstract]   [Full Text] [Related]  

  • 9. The first case of a patient with neutropenia and giant-cell arteritis treated with rituximab.
    Mayrbaeurl B; Hinterreiter M; Burgstaller S; Windpessl M; Thaler J
    Clin Rheumatol; 2007 Sep; 26(9):1597-8. PubMed ID: 17619810
    [No Abstract]   [Full Text] [Related]  

  • 10. Benefit of high-dose intravenous methylprednisolone as induction therapy for giant cell arteritis: comment on the article by Mazlumzadeh et al.
    Arashvand K
    Arthritis Rheum; 2007 May; 56(5):1722; author reply 1723-4. PubMed ID: 17469170
    [No Abstract]   [Full Text] [Related]  

  • 11. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
    Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
    Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis.
    Bhatia A; Ell PJ; Edwards JC
    Ann Rheum Dis; 2005 Jul; 64(7):1099-100. PubMed ID: 15958774
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infliximab is ineffective against giant cell arteritis and polymyalgia rheumatica].
    Krüger K
    Z Rheumatol; 2007 Oct; 66(6):536-7. PubMed ID: 17849125
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis.
    Berger CT; Recher M; Daikeler T
    Rheumatology (Oxford); 2018 Jan; 57(1):196-197. PubMed ID: 28968856
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.
    Bertoli AM; Font YM; Nadal A; Vilá LM
    Arthritis Rheum; 2007 May; 56(5):1723; author reply 1723-4. PubMed ID: 17469171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction therapy with corticoid pulses for treatment of temporal arteritis].
    Krüger K
    Z Rheumatol; 2007 Mar; 66(2):165-6. PubMed ID: 17294060
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab efficiency and failure.
    Rozin AP
    Ann Rheum Dis; 2004 Jun; 63(6):751-2; author reply 752. PubMed ID: 15140791
    [No Abstract]   [Full Text] [Related]  

  • 18. Tocilizumab in Giant Cell Arteritis.
    Mariano VJ; Frishman WH
    Cardiol Rev; 2018; 26(6):321-330. PubMed ID: 29570475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2017; 106(22):1251-1252. PubMed ID: 29088969
    [No Abstract]   [Full Text] [Related]  

  • 20. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial.
    Seror R; Baron G; Hachulla E; Debandt M; Larroche C; Puéchal X; Maurier F; de Wazieres B; Quéméneur T; Ravaud P; Mariette X
    Ann Rheum Dis; 2014 Dec; 73(12):2074-81. PubMed ID: 23897775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.